UB Paderborn / Katalog / Suche / in CDI

A 1 adenosine receptor agonists and their potential therapeutic applications

Expert opinion on investigational drugs, 2008-12, Vol.17 (12), p.1901-1910

2008

Volltextzugriff (PDF)

2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists

Journal of medicinal chemistry, 2004-09, Vol.47 (19), p.4766-4773

2004

Volltextzugriff (PDF)

2-Pyrazolyl-N 6 -Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A 3 Receptor Agonists

Journal of medicinal chemistry, 2004-09, Vol.47 (19), p.4766-4773

2004

Volltextzugriff (PDF)

2-Pyrazolyl-N6-Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A3 Receptor Agonists

Journal of medicinal chemistry, 2004-09, Vol.47 (19), p.4766-4773

2004

Volltextzugriff (PDF)

A 2B adenosine receptor antagonists and their potential indications

Expert opinion on therapeutic patents, 2006-10, Vol.16 (10), p.1347-1357

2006

Volltextzugriff (PDF)

A1 adenosine receptor agonists and their potential therapeutic applications

Expert opinion on investigational drugs, 2008-12, Vol.17 (12), p.1901-1910

2008

Volltextzugriff (PDF)

A1 adenosine receptor antagonists, agonists, and allosteric enhancers

Handbook of experimental pharmacology, 2009 (193), p.25

2009

Volltextzugriff (PDF)

A2B adenosine receptor antagonists and their potential indications

Expert opinion on therapeutic patents, 2006-10, Vol.16 (10), p.1347-1357

2006

Volltextzugriff (PDF)

Addendum: Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis

Nature medicine, 2011-02, Vol.17 (2), p.229-229

2011

Volltextzugriff (PDF)

Affinity and intrinsic efficacy (IE) of 5′-carbamoyl adenosine analogues for the A 1 adenosine receptor—efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF)

Bioorganic & medicinal chemistry letters, 2004, Vol.14 (2), p.535-539

2004

Volltextzugriff (PDF)

Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor: efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF)

Bioorganic & medicinal chemistry letters, 2004-01, Vol.14 (2), p.535-539

2004

Volltextzugriff (PDF)

Chapter 13 Recent Advances in Adenosine Receptor (AR) Ligands in Pulmonary Diseases

Annual Reports in Medicinal Chemistry, 2009, Vol.44, p.265-277

2009

Volltextzugriff (PDF)

Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists

Naunyn-Schmiedeberg's archives of pharmacology, 2007-04, Vol.375 (2), p.133-144

2007

Volltextzugriff (PDF)

CVT-4325: A Potent Fatty Acid Oxidation Inhibitor with Favorable Oral Bioavailability

ChemInform, 2005-04, Vol.36 (15), p.no-no

2005

Volltextzugriff (PDF)

CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability

Bioorganic & medicinal chemistry letters, 2004-12, Vol.14 (24), p.6017-6021

2004

Volltextzugriff (PDF)

Discovery of a Novel A 2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

Journal of medicinal chemistry, 2008-04, Vol.51 (7), p.2267-2278

2008

Volltextzugriff (PDF)

Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

Journal of medicinal chemistry, 2008-04, Vol.51 (7), p.2267-2278

2008

Volltextzugriff (PDF)

The discovery of a selective, high affinity A 2B adenosine receptor antagonist for the potential treatment of asthma

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (3), p.609-612

2005

Volltextzugriff (PDF)

The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (3), p.609-612

2005

Volltextzugriff (PDF)

The Discovery of a Selective, High Affinity A 2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma

ChemInform, 2005-06, Vol.36 (25)

Zablocki, Jeff

2005

Volltextzugriff (PDF)

The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (3), p.609-612

2005

Volltextzugriff (PDF)

The Discovery of a Selective, High Affinity A2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma

ChemInform, 2005-06, Vol.36 (25), p.no-no

2005

Volltextzugriff (PDF)

Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I Nai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties

Journal of medicinal chemistry, 2016-10, Vol.59 (19), p.9005-9017

2016

Volltextzugriff (PDF)

Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B

Journal of medicinal chemistry, 2020-09, Vol.63 (18), p.10188-10203

2020

Volltextzugriff (PDF)

Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)

Bioorganic & medicinal chemistry letters, 2018-02, Vol.28 (3), p.541-546

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A 1 adenosine receptor agonists and their potential therapeutic applications

2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists

2-Pyrazolyl-N 6 -Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A 3 Receptor Agonists

2-Pyrazolyl-N6-Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A3 Receptor Agonists

A 2B adenosine receptor antagonists and their potential indications

A1 adenosine receptor agonists and their potential therapeutic applications

A1 adenosine receptor antagonists, agonists, and allosteric enhancers

A2B adenosine receptor antagonists and their potential indications

Addendum: Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis

Affinity and intrinsic efficacy (IE) of 5′-carbamoyl adenosine analogues for the A 1 adenosine receptor—efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF)

Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor: efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF)

Chapter 13 Recent Advances in Adenosine Receptor (AR) Ligands in Pulmonary Diseases

Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists

CVT-4325: A Potent Fatty Acid Oxidation Inhibitor with Favorable Oral Bioavailability

CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability

Discovery of a Novel A 2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

The discovery of a selective, high affinity A 2B adenosine receptor antagonist for the potential treatment of asthma

The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma

The Discovery of a Selective, High Affinity A 2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma

The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma

The Discovery of a Selective, High Affinity A2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma

Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I Nai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties

Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B

Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)

Suchergebnisse filtern